Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 4 hours ago
BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
about 4 hours ago
Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as...
Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
about 7 hours ago
As Eli Lilly gets off to the races with the launch of...
Merck's growth products Winrevair, Ohtuvayre trending in opposite directions
about 7 hours ago
While Merck's PAH treatment Winrevair continued its upward trajectory, another of its...
Merck bats for heart disease awareness with new baseball-inspired campaign
about 9 hours ago
Merck is making its pitch that high levels of so-called “bad cholesterol”...
Europe’s drug regulator sets up new group to counter vaccine hesitancy
about 9 hours ago
The European Medicines Agency (EMA) has launched an advisory group designed to...
Amarox recalls batch of antidepressants in UK over packaging mix-up
about 10 hours ago
Amarox, the U.K. unit of India’s Hetero Group, issued a voluntary recall...
Novartis rounds out $23B US investment push with plans for North Carolina API plant
about 11 hours ago
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North...
Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
about 12 hours ago
The FDA has reprimanded Bayer for the “attention-grabbing visuals” and “frequent scene...
Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
about 14 hours ago
Avalyn Pharma has overshot its expectations with a $300 million IPO that...
US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
about 17 hours ago
Patient groups’ perceptions of drugmakers with large U.S. footprints have shifted in...
With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
1 day ago
While Teva Pharmaceutical’s multiyear growth streak under CEO Richard Francis showed signs...
AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
1 day ago
As AstraZeneca braces for the impact of the U.S. “most favored nation”...